<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7435512\results\search\drug\results.xml">
  <result pre="envelope protein ExoN exonuclease FDA Food and Drug Administration HCQ" exact="hydroxychloroquine" post="HIV human immunodeficiency virus IFN interferon IL interleukin M"/>
  <result pre="hydrochloride Endocytosis/inhibition membrane fusion (38, 39, 40) NCT04252885 (41, 42)" exact="Ribavirin" post="RNA polymerase/inhibition (43, 44) No data Remdesivir RNA polymerase/inhibition"/>
  <result pre="Trial (42, 51) Î²â€�dâ€�N4â€�hydroxycytidine RNA polymerase/inhibition (52, 53) No data" exact="Sofosbuvir" post="RNA polymerase/inhibition (54) No data Î±â€�ketoamide inhibitor Proteases/inhibition (55)"/>
  <result pre="polymerase/inhibition (54) No data Î±â€�ketoamide inhibitor Proteases/inhibition (55) No data" exact="Ritonavir" post="Proteases/inhibition (56) NCT04252885 (41, 49, 57, 58, 59) Lopinavir"/>
  <result pre="Lopinavir Proteases/inhibition (56, 60) NCT04252885 (41, 49, 57, 58, 59)" exact="Nelfinavir" post="Proteases/inhibition (61) No data Dolutegravir Proteases/inhibition (39) No data"/>
  <result pre="the first clinical trials reported that lopinavir, combined with the" exact="ritonavir" post="that boosts lopinavir levels by interfering with cytochrome P450"/>
  <result pre="trials reported that lopinavir, combined with the ritonavir that boosts" exact="lopinavir" post="levels by interfering with cytochrome P450 metabolism, does not"/>
  <result pre="Indeed, in vitro studies show that SARSâ€�CoV polymerase can incorporate" exact="ribavirin" post="triphosphate during replication, but this purine NA is detected"/>
  <result pre="mechanism.68 This might partly explain the poor antiviral effect of" exact="ribavirin" post="in SARSâ€� and MERSâ€�CoV infection.43, 70 On the other"/>
  <result pre="hepatitis C virus infection management. A recent study showed that" exact="sofosbuvir" post="triphosphate is incorporated by recombinant SARSâ€�CoVâ€�2 RdRp during RNA"/>
  <result pre="analysis of their results reveals that some compounds, such as" exact="chloroquine" post="derivatives, have been identified in different experimental conditions. Moreover,"/>
  <result pre="Compounds Target/MoA Tests in vitro (CoV) Clinical trials SARSâ€�CoVâ€�2 Antivirals" exact="Nafamostat" post="mesylate TMPRSS2/inhibitor (92) No data Camostat mesylate TMPRSS2/inhibitor (39,"/>
  <result pre="(92) No data Camostat mesylate TMPRSS2/inhibitor (39, 92) No data" exact="Chloroquine" post="Hydroxychloroquine pH increases in endosomal compartment (39, 48, 93,"/>
  <result pre="No data Camostat mesylate TMPRSS2/inhibitor (39, 92) No data Chloroquine" exact="Hydroxychloroquine" post="pH increases in endosomal compartment (39, 48, 93, 94,"/>
  <result pre="93, 94, 95, 96) â€œSolidarity,â€� â€œDiscoveryâ€� NCT04358068 (49, 97, 98)" exact="Azithromycin" post="(antibiotic) pH increases in endosomal compartment/immunomodulator (39) NCT04358068 (98)"/>
  <result pre="Azithromycin (antibiotic) pH increases in endosomal compartment/immunomodulator (39) NCT04358068 (98)" exact="Omeprazole" post="PPI (39) No data Vonoprazan PPI (39) No data"/>
  <result pre="approved for clinical use, blocks S protein processing inâ€‰vitro.92 Moreover," exact="camostat" post="mesylate and its derivative nafamostat mesylate can inhibit (in"/>
  <result pre="S protein processing inâ€‰vitro.92 Moreover, camostat mesylate and its derivative" exact="nafamostat" post="mesylate can inhibit (in the nM to Î¼M range)"/>
  <result pre="protein priming blocks ACE2â€�mediated entry. However, the inhibition observed with" exact="camostat" post="mesylate and nafamostat mesylate in VeroE6 cells infected by"/>
  <result pre="ACE2â€�mediated entry. However, the inhibition observed with camostat mesylate and" exact="nafamostat" post="mesylate in VeroE6 cells infected by SARSâ€�CoVâ€�2 is lower"/>
  <result pre="lower and probably not enough for a therapeutic utilization of" exact="camostat" post="mesylate. The picture is further complicated because other cellular"/>
  <result pre="Two recent studies showed that proton pump inhibitors, such as" exact="omeprazole" post="and vonoprazan, reduce the infection of cells by SARSâ€�CoVâ€�2.39,"/>
  <result pre="reduce the infection of cells by SARSâ€�CoVâ€�2.39, 64 In addition," exact="chloroquine" post="and hydroxychloroquine (HCQ), which have been extensively used for"/>
  <result pre="infection of cells by SARSâ€�CoVâ€�2.39, 64 In addition, chloroquine and" exact="hydroxychloroquine" post="(HCQ), which have been extensively used for the treatment"/>
  <result pre="levels and does not protect macaques against SARSâ€�CoV infection.108 Moreover," exact="chloroquine" post="derivatives have immunosuppressive effects and inhibit the activation of"/>
  <result pre="have also suggested the therapeutic effect of the HCQâ€�azithromycin combination.98" exact="Azithromycin" post="is an antibiotic that has also antiviral activity in"/>
  <result pre="antiviral activity in respiratory viral infections.111 Interestingly, the MoA of" exact="azithromycin" post="and HCQ may be related to the modulation of"/>
  <result pre="of the endosomal and transâ€�Golgi network pH.112, 113 In addition," exact="azithromycin" post="plays a role in regulating interleukin production that might"/>
  <result pre="control the immune response and prevent symptom worsening.114, 115, 116" exact="Azithromycin" post="may also inhibit viral invasion by interfering with the"/>
  <result pre="have removed their support for the use of HCQ and" exact="chloroquine" post="for COVIDâ€�19, consequently the status of ongoing trials must"/>
  <result pre="must be questioned. More recently, it has been reported that" exact="ivermectin" post="inhibits SARSâ€�CoVâ€�2 with an ~5000â€�fold reduction in viral RNA"/>
  <result pre="S A. 2020;117(12):6771â€�6776.32054787 48WangM, CaoR, ZhangL, et al. Remdesivir and" exact="chloroquine" post="effectively inhibit the recently emerged novel coronavirus (2019â€�nCoV) in"/>
  <result pre="Chemother. 2014;58(8):4875â€�4884.24841269 61YamamotoN, YangR, YoshinakaY, et al. HIV protease inhibitor" exact="nelfinavir" post="inhibits replication of SARSâ€�associated coronavirus. Biochem Biophys Res Commun."/>
  <result pre="2020. 65CrottyS, MaagD, ArnoldJJ, et al. The broadâ€�spectrum antiviral ribonucleoside" exact="ribavirin" post="is an RNA virus mutagen. Nat Med. 2000;6(12):1375â€�1379.11100123 66PruijssersAJ,"/>
  <result pre="Virol. 2019;35:57â€�62.31125806 67FeldJJ, HoofnagleJH. Mechanism of action of interferon and" exact="ribavirin" post="in treatment of hepatitis C. Nature. 2005;436(7053):967â€�972.16107837 68FerronF, SubissiL,"/>
  <result pre="et al. Structural and molecular basis of mismatch correction and" exact="ribavirin" post="excision from coronavirus RNA. Proc Natl Acad Sci U"/>
  <result pre="Antimicrob Agents Chemother. 2002;46(4):977â€�981.11897578 74KimJâ€�A, SeongRâ€�K, KumarM, ShinOS. Favipiravir and" exact="ribavirin" post="inhibit replication of Asian and African strains of Zika"/>
  <result pre="strategies. J Biol Regul Homeost Agents. 2020;34(2). 91LedfordH. Coronavirus breakthrough:" exact="dexamethasone" post="is first drug shown to save lives. Nature. 2020;582:46932546811"/>
  <result pre="save lives. Nature. 2020;582:46932546811 92HoffmannM, SchroederS, Kleineâ€�WeberH, MÃ¼llerMA, DrostenC, PÃ¶hlmannS." exact="Nafamostat" post="Mesylate Blocks Activation of SARSâ€�CoVâ€�2: New Treatment Option. The"/>
  <result pre="http://aac.asm.org/. Accessed April 27, 2020. 93VincentMJ, BergeronE, BenjannetS, et al." exact="Chloroquine" post="is a potent inhibitor of SARS coronavirus infection and"/>
  <result pre="vitro antiviral activity and projection of optimized dosing design of" exact="hydroxychloroquine" post="for the treatment of severe acute respiratory syndrome coronavirus"/>
  <result pre="infection in vitro. Cell Discov. 2020;6(1):16.32194981 97GaoJ, TianZ, YangX. Breakthrough:" exact="chloroquine" post="phosphate has shown apparent efficacy in treatment of COVIDâ€�19"/>
  <result pre="clinical studies. Biosci Trends. 2020;14(1):72â€�73.32074550 98GautretP, LagierJâ€�C, ParolaP, et al." exact="Hydroxychloroquine" post="and azithromycin as a treatment of COVIDâ€�19: results of"/>
  <result pre="Biosci Trends. 2020;14(1):72â€�73.32074550 98GautretP, LagierJâ€�C, ParolaP, et al. Hydroxychloroquine and" exact="azithromycin" post="as a treatment of COVIDâ€�19: results of an openâ€�label"/>
  <result pre="and mortality. JAMA. 2020;126:1671â€&quot;1681. 104HoffmannM, SchroederS, Kleineâ€�WeberH, MÃ¼llerMA, DrostenC, PÃ¶hlmannS." exact="Nafamostat" post="mesylate blocks activation of SARSâ€�CoVâ€�2: new treatment option for"/>
  <result pre="Cell. 2020;181:271â€&quot;280. 32142651 106SavarinoA, BoelaertJR, CassoneA, MajoriG, CaudaR. Effects of" exact="chloroquine" post="on viral infections: an old drug against today's diseases."/>
  <result pre="J Antimicrob Agents. 2020;106028http://dx.doi/10.1016/j.ijantimicag.2020.10602832450198 109SchrezenmeierE, DÃ¶rnerT. Mechanisms of action of" exact="hydroxychloroquine" post="and chloroquine: implications for rheumatology. Nat Rev Rheumatol. 2020;16(3):155â€�166.32034323"/>
  <result pre="Antimicrobial Chemotherapy. https://www.isac.world/news-and-publications/official-isac-statement. Accessed April 30, 2020. 111GielenV, JohnstonSL, EdwardsMR." exact="Azithromycin" post="induces antiâ€�viral responses in bronchial epithelial cells. Eur Respir"/>
  <result pre="in bronchial epithelial cells. Eur Respir J. 2010;36(3):646â€�654.20150207 112DereticV, TimminsGS." exact="Azithromycin" post="and ciprofloxacin have a chloroquineâ€�like effect on respiratory epithelial"/>
  <result pre="epithelial cells. Eur Respir J. 2010;36(3):646â€�654.20150207 112DereticV, TimminsGS. Azithromycin and" exact="ciprofloxacin" post="have a chloroquineâ€�like effect on respiratory epithelial cells. bioRxiv."/>
  <result pre="113PaniA, LauriolaM, RomandiniA, ScaglioneF. Macrolides and viral infections: focus on" exact="azithromycin" post="in COVIDâ€�19 pathology. Int J Antimicrob Agents. 2020;106053.32534189 114AghaiZH,"/>
  <result pre="Int J Antimicrob Agents. 2020;106053.32534189 114AghaiZH, KodeA, SaslowJG, et al." exact="Azithromycin" post="suppresses activation of nuclear factorâ€�kappa B and synthesis of"/>
  <result pre="cells from premature infants. Pediatr Res. 2007;62(4):483â€�488.17667842 115TaylorSP, SellersE, TaylorBT." exact="Azithromycin" post="for the prevention of COPD exacerbations: the good, bad,"/>
  <result pre="and ugly. Am J Med. 2015;128(12):1362. 116BouwmanJJ, VisserenFL, BouterPK, DieperslootRJ." exact="Azithromycin" post="inhibits interleukinâ€�6 but not fibrinogen production in hepatocytes infected"/>
  <result pre="CD147 as a target for COVIDâ€�19 treatment: suggested effects of" exact="azithromycin" post="and stem cell engagement. Stem Cell Rev Reports. 2020;16:434â€&quot;440."/>
 </snippets>
</snippetsTree>
